VTE with Amivantamab plus Chemotherapy in NSCLC.

Moik, Florian; Riedl, Jakob M; Ay, Cihan

Moik, Florian; Riedl, Jakob M; Ay, Cihan.

Affiliation

Moik F; Medical University of Graz, Graz, Austria florian.moik@medunigraz.at.
Riedl JM; Medical University of Graz, Graz, Austria florian.moik@medunigraz.at.
Ay C; Medical University of Vienna, Vienna, Austria.

N Engl J Med ; 390(6): 578-579, 2024 Feb 08.

Article in En | MEDLINE | ID: mdl-38324502

Subject(s)

Antibodies, Bispecific; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Venous Thromboembolism; Humans; Venous Thromboembolism/drug therapy; Carcinoma, Non-Small-Cell Lung/complications; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/complications; Lung Neoplasms/drug therapy; ErbB Receptors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Carcinoma, Non-Small-Cell Lung / Venous Thromboembolism / Lung Neoplasms Limits: Humans Language: En Journal: N Engl J Med Year: 2024 Type: Article Affiliation country: Austria

Fulltext

XML

PubMed Links

Search on Google